How Nurses Can Support Physicians in Identifying Colorectal Cancer Risk

Video

Ascertaining family history and promoting screening are key.

Nurses can support providers in identifying patients’ colorectal cancer risk by enabling them with the tools and information needed to assess it.

“Colorectal cancer is the most preventable solid tumor on the planet,” says Thomas Weber, MD, FACS, founder and president of the Colon Cancer Foundation.

In this video, Weber explains how nurses can focus on ascertaining patients’ family history and ensuring that patients get their colonoscopies when they are due.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
Image of a woman with light brown hair wearing glasses with a blue background
Image of a woman wearing glasses in front of a blue background
Image of a woman with glasses in front of a blue background
Image of a man in a suit smiling in front of an Oncology Nursing News background
Related Content
Photo of a woman with brown hair and bangs, surrounded by a blue border

AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

Michelle Kirschner, RN, MSN, ACNP, APRN-BC
June 30th 2025
Article

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.

The Vitals

ctDNA Monitoring is a Piece of the Puzzle in CRC Treatment

Lindsay Fischer
October 31st 2023
Podcast

Holly Chitwood, DNP, FNP-C, AGACNP-BC, explains how circulating tumor DNA monitoring helps providers screen minimal residual disease in individuals with colorectal cancer.

Illustration of a pancreas on a blue background

Novel ADC Receives FDA Fast Track Designation for Pancreatic Cancer

Sabrina Serani
May 30th 2025
Article

The novel antibody-drug conjugate EBC-129 has been fast tracked by the FDA for approval in pancreatic ductal adenocarcinoma.

The Vitals

Terri Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium

Lindsay Fischer
March 1st 2023
Podcast

In this episode of "The Vitals," Terri Pollack, DNP, APRN, FNP-C, PMHNP-BC, underscores potentially practice-changing data which were presented during the 2023 GI Cancers Symposium.

Graphic reading "FDA APPROVED" resembling a seal of approval

Retifanlimab Receives FDA Approval for Advanced Anal Cancer

Bridget Hoyt
May 15th 2025
Article

Retifanlimab has received approval for the frontline treatment of advanced anal cancer from the FDA.

pancreatic ductal adenocarcinoma

Proactive Management of NALIRIFOX-Related Diarrhea Is Crucial in Metastatic PDAC

Ashley Chan
April 12th 2025
Article

Assessing the signs and symptoms of chemotherapy-induced diarrhea and providing accurate and timely patient education may reduce complications and optimize survival outcomes.